RxDoctor Payments DataLook up a doctor →

Lori Blackburn, PA

Medical · Morristown, TNNPI 1780791749

Payments from drug & device makers

$6,275in general payments, 2019–2025

Across 452 payments — averaging $13.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$812
  • GSK$634
  • AstraZeneca$631
  • Boehringer Ingelheim$257
  • Pfizer$224
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$6,275100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,275 in reported general payments places this provider in the 90th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$73,357
Medicare patients
195
Services billed
1,750

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide167$221,732
Trelegy ElliptaFluticasone/Umeclidin/Vilanter252$188,852
Tresiba Flextouch U-200Insulin Degludec71$151,406
JardianceEmpagliflozin93$113,143
EliquisApixaban102$105,976
TrintellixVortioxetine Hydrobromide106$95,858
LinzessLinaclotide112$93,652
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog44$73,225
VraylarCariprazine Hcl46$67,875
XareltoRivaroxaban77$64,579
OtezlaApremilast13$63,976
RexultiBrexpiprazole36$55,794
TradjentaLinagliptin42$53,898
MounjaroTirzepatide45$50,765
FarxigaDapagliflozin Propanediol59$47,897

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$812$252,110192 claims
AbbVieLinzess, Vraylar, Creon, Ubrelvy$1,266$225,382182 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$634$216,326301 claims
Boehringer IngelheimJardiance, Tradjenta, Glyxambi$257$207,348169 claims
PfizerEliquis, Nurtec Odt$224$129,582116 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$64$95,858106 claims
Lilly USA, LLCMounjaro, Trulicity$90$83,22169 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$631$78,009111 claims
Johnson & JohnsonXarelto$219$64,57977 claims
AmgenOtezla$148$63,97613 claims
Otsuka America Pharmaceutical, Inc.Rexulti$136$55,79436 claims
Astellas Pharma US IncMyrbetriq$26$40,95847 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 480 medical providers in Tennessee.

Other medical in Morristown

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →